We are live on
!
Find out more
Twist Bioscience
TWST
TWST
279 hedge funds and large institutions have $3.66B invested in Twist Bioscience in 2026 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 76 increasing their positions, 88 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
169% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 26
75% more call options, than puts
Call options by funds: $10.8M | Put options by funds: $6.18M
53% more capital invested
Capital invested by funds: $2.39B → $3.66B (+$1.27B)
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
15% more funds holding
Funds holding: 243 → 279 (+36)
2.94% more ownership
Funds ownership: 122.67% → 125.6% (+2.9%)
14% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 88
Holders
279
Holders Change
+36
Holders Change %
+14.81%
% of All Funds
3.43%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.06%
New
70
Increased
76
Reduced
88
Closed
26
Calls
$10.8M
Puts
$6.18M
Net Calls
+$4.64M
Net Calls Change
+$3.59M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$81.6M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$63.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$53.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$39.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30M |
